Adenosine
NDC 25021-318, Adenosine, injection, from Sagent Pharmaceuticals.
- Product NDC
- 25021-318
- Status
- Listed
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206778
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25021-318 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ADENOSINE3 mg/mL
Pharmacologic classes
Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25021-318-02 | 25021031802 | 10 VIAL in 1 CARTON (25021-318-02) / 2 mL in 1 VIAL |
| 25021-318-04 | 25021031804 | 10 VIAL in 1 CARTON (25021-318-04) / 4 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/546642f2-662f-46cf-9d82-5bb3bdcc7677Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=25021-318
Use it
Look up 25021-318 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25021-318 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25021-318. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.